Guanidinoacetic Acid as a Nutritional Adjuvant to Multiple Sclerosis Therapy
Tackling impaired bioenergetics in multiple sclerosis (MS) has been recently recognized as an innovative approach with therapeutic potential. Guanidinoacetic acid (GAA) is an experimental nutrient that plays a significant role in high-energy phosphate metabolism. The preliminary trials suggest benef...
Main Author: | Sergej M. Ostojic |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Human Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnhum.2022.871535/full |
Similar Items
-
Guanidinoacetic acid in human nutrition: Beyond creatine synthesis
by: Sergej M. Ostojic, et al.
Published: (2023-04-01) -
Short‐term GAA loading: Responders versus nonresponders analysis
by: Sergej M. Ostojic
Published: (2020-08-01) -
Short-term fasting affects biomarkers of creatine metabolism in healthy men and women
by: Marijana Ranisavljev, et al.
Published: (2023-12-01) -
Safety of Dietary Guanidinoacetic Acid: A Villain of a Good Guy?
by: Sergej M. Ostojic
Published: (2021-12-01) -
Cataloguing guanidinoacetic acid content in nutritional supplements
by: Sergej M. Ostojic, et al.
Published: (2023-04-01)